BBG Advanced Therapies Launches Mobile Leukapheresis Center, in Collaboration with Kite to Bring CAR T-cell Therapies Closer to Patients

BBG Advanced Therapies, a subsidiary of BioBridge Global, has partnered with Kite (a Gilead Company) to deploy a Mobile Leukapheresis Center across Texas. This first-of-its-kind platform brings T-cell collection directly to patients' communities, reducing travel burdens and expanding access to Kite's CAR T-cell therapies for blood cancer treatment. The initiative addresses the gap where only 2 in 10 eligible U.S. patients currently receive these treatments.